6533b854fe1ef96bd12ae13e

RESEARCH PRODUCT

[Metabolic syndrome in patients with coronary heart disease. Results of using different diagnostic criteria].

Concepción Riera FortunyCarlos Morillas AriñoPilar Cubells CascalesMaría Morales Suárez-varelaMaría Luisa Martínez TrigueroAntonio Hernández Mijares

subject

AdultMalemedicine.medical_specialtymedicine.medical_treatmentCoronary DiseaseDiseaseDiabetes mellitusInternal medicineMedicineHumansNational Cholesterol Education ProgramAgedMetabolic Syndromebusiness.industryInsulinGeneral MedicineMiddle Agedmedicine.diseaseObesityCoronary heart diseaseCross-Sectional StudiesCardiologyObservational studyFemaleMetabolic syndromebusinessBlood Chemical Analysis

description

A unified definition of metabolic syndrome, considered a common feature of cardiovascular risk, is lacking. The aim of this study was to compare the prevalence of this syndrome in patients with ischemic heart disease using two diagnostic criteria: the European Group of Resistance to Insulin and the National Cholesterol Education Program. We designed an observational, cross-sectional study of the factors that make up metabolic syndrome in subjects diagnosed with coronary heart disease. A total of 169 patients aged 35 to 79 years were studied (129 men and 40 women). With the European group criterion the percentage of patients with metabolic syndrome was 43.7%, whereas the American group criterion yielded a prevalence of 40.8% (no significant difference). The prevalence of metabolic syndrome among patients with ischemic heart disease is high. The diagnostic criteria used are similar and do not differ significantly, although diagnostic concordance was only 50%.

yearjournalcountryeditionlanguage
2004-09-18Revista espanola de cardiologia
https://pubmed.ncbi.nlm.nih.gov/15373996